Submitted by yahooentertainment6306 in business
(Bloomberg) -- Insmed Inc. shares more than doubled after the company’s experimental drug reduced episodes of worsening symptoms in a final-stage study of...
Submitted by yahooentertainment6306 in business
(Bloomberg) -- Insmed Inc. shares more than doubled after the company’s experimental drug reduced episodes of worsening symptoms in a final-stage study of...